Faithward Advisors Boosts HealthEquity Stake to $4.41 Million

Institutional investor adds 46,580 shares of the healthcare financial services company

Mar. 18, 2026 at 10:34am

Faithward Advisors LLC, an institutional investor, acquired a new position in HealthEquity, Inc. (NASDAQ:HQY) during the third quarter, according to a recent SEC filing. The firm purchased 46,580 shares of the company's stock, valued at approximately $4,414,000, giving it a 0.05% ownership stake in HealthEquity.

Why it matters

HealthEquity is a leading provider of consumer-directed healthcare accounts and services, including health savings accounts (HSAs), flexible spending accounts (FSAs), and health reimbursement arrangements (HRAs). The company's growth has attracted interest from institutional investors like Faithward Advisors, who see potential in HealthEquity's position in the expanding consumer-directed healthcare market.

The details

According to the 13F filing, Faithward Advisors acquired the new position in HealthEquity during the third quarter of the reporting period. The 46,580 shares purchased represent a $4.41 million investment in the company. HealthEquity provides account management, cost transparency, and healthcare spending tools to employers, health plans, and individuals across the United States.

  • Faithward Advisors acquired the HealthEquity position in the third quarter of the reporting period.

The players

Faithward Advisors LLC

An institutional investor that acquired a new position in HealthEquity, Inc.

HealthEquity, Inc.

A leading provider of consumer-directed healthcare accounts and services, including health savings accounts (HSAs), flexible spending accounts (FSAs), and health reimbursement arrangements (HRAs).

Got photos? Submit your photos here. ›

The takeaway

The investment by Faithward Advisors in HealthEquity reflects the growing interest in consumer-directed healthcare solutions as employers and individuals seek more control and transparency over their healthcare spending. HealthEquity's position as a leading provider in this market makes it an attractive target for institutional investors looking to capitalize on this trend.